Welcome to our dedicated page for Healthcare Triangle news (Ticker: HCTI), a resource for investors and traders seeking the latest updates and insights on Healthcare Triangle stock.
Healthcare Triangle, Inc. reports developments in healthcare information technology, digital health platforms, cloud enablement, managed services, and data analytics for healthcare and life sciences organizations. Company news includes product and customer updates involving hospital information management, interoperability, telehealth, AI-powered clinical and operational automation, and customer-engagement tools.
Recurring HCTI updates also cover subsidiary activity at QuantumNexis, international expansion across Africa, the Middle East, and related healthcare markets, partnership and joint-venture activity, and capital-structure actions such as share repurchase authorization and reverse stock split disclosures.
Healthcare Triangle (Nasdaq:HCTI) reported strong Q1 2026 results, driven by its January acquisition of Teyame 360 and Datono.
Revenue rose 166% year-over-year to $9.9M, while gross profit increased 627% to $2.4M and gross margin expanded from 9% to 24%.
The new Customer Engagement Services segment, created from the acquired businesses, delivered $6.9M revenue (about 70% of total), $2.0M gross profit and roughly 29% segment margin, offsetting modest declines in legacy Software Services and Managed Services. Management expects further gross margin improvement as integration and cross-selling progress.
Healthcare Triangle (NASDAQ: HCTI) launched ZoraNex, an AI-driven digital self-care therapy platform developed by subsidiary QuantumNexis, targeting mild-to-moderate stress, anxiety, depression, and sleep issues. ZoraNex will be available on Apple App Store and Google Play before end of Q2 2026 and targets a global mental health market valued at $450B (2024).
The platform combines evidence-based psychotherapies with Eastern mind-body practices, avatar-led sessions, wearable integration, and a hybrid DTC and enterprise go-to-market focused on Southeast Asia (Malaysia first).
Healthcare Triangle (Nasdaq: HCTI) announced that subsidiary QuantumNexis has won healthcare customers in Kenya, Botswana, and Tanzania, with active engagements in Uganda and Egypt, and a strategic LIMS partnership in Ethiopia. Market context: MENA healthcare services are valued at USD 241.13B (2024) and projected to reach USD 412.25B by 2032 at a 7.0% CAGR. The company highlights deployment of the Ezovion Hospital Information Management System (HIMS) to enable digital care pathways, telehealth, unified records, AI insights, and secure cloud infrastructure across emerging African markets.
Healthcare Triangle (Nasdaq: HCTI) announced deployment of an Agentic AI solution into Teyame.AI's Customer Engagement Platform on March 25, 2026, targeting U.S. and Latin American expansion.
The release cites a projected global agentic AI market rising from $7.5B (2025) to $199.05B by 2034 (45% CAGR) and highlights multilingual, omnichannel automation, real‑time lead scoring, security/compliance features, and cross‑channel context preservation.
Healthcare Triangle (Nasdaq: HCTI) announced that its Board approved a $2,000,000 share repurchase plan on March 9, 2026, effective immediately. The plan permits repurchases via open-market or negotiated transactions, including Rule 10b-18 and Rule 10b5-1 plans, funded from available cash or other liquidity.
The program is discretionary, may be suspended or discontinued, and does not obligate the company to repurchase any specific amount; repurchased shares may be held as treasury stock or retired.
Healthcare Triangle (Nasdaq: HCTI) subsidiary QuantumNexis launched Dubai operations in Meydan Free Zone on Feb 27, 2026 to deliver clinically validated digital mental health solutions and an AI-powered Hospital Information System across GCC markets.
The expansion emphasizes national interoperability (openEHR), Microsoft and Better.care partnerships, and alignment with UAE NABIDH/Riayati and Saudi Vision 2030. Market notes: UAE digital health projected at USD 1.84B by 2030 and Saudi at over USD 11B by 2033.
Healthcare Triangle (Nasdaq: HCTI) entered definitive agreements for a registered direct offering of 681,553 shares (or prefunded warrants) at $5.81 per share, expected to close on or about February 27, 2026. Gross proceeds are expected to be approximately $3.959 million before fees and expenses. D. Boral Capital is sole placement agent. The offering is made under an existing Form S-3 shelf registration declared effective January 31, 2024; a prospectus supplement will be filed with the SEC.
Healthcare Triangle (Nasdaq: HCTI) subsidiary QuantumNexis announced a strategic partnership with TNG Digital on Feb 25, 2026 to embed clinically validated digital mental health services into TNG eWallet for over 25 million Malaysian users.
The integration will deliver in-app assessments, licensed professional access, multilingual support, and a transaction-based revenue model with expected meaningful adoption in 6–12 months.
Healthcare Triangle (Nasdaq: HCTI) will effect a 1-for-60 reverse stock split effective 12:01 a.m. ET on February 10, 2026, with post-split trading on Nasdaq at market open February 10, 2026, pending DTC and Nasdaq confirmations.
The split was approved by stockholders on February 2, 2026, assigns new CUSIP 42227W405, reduces outstanding shares from ~45,417,091 to ~756,952, and is intended to help the company regain compliance with Nasdaq's $1.00 minimum bid price. Stockholders of record as of January 8, 2026 will receive post-split information from transfer agent VStock Transfer.
Healthcare Triangle (Nasdaq: HCTI) subsidiary QuantumNexis announced a joint venture with Golden Code Holdings to accelerate AI and digital health transformation in Saudi Arabia, targeting the $70 billion Saudi healthcare market by 2030. The JV will deploy interoperable, open‑standards platforms (Ezovion, Ziloy.ai, Readabl.ai, openEHR) and partner with Microsoft and Better.care to support Saudi Vision 2030, build local workforce capability, and establish a Middle East hub for innovation, research, and co‑development across hospitals, clinics, and national health programs.